Article
Beneath the radar: immune-evasive cell sources for stroke therapy
25 Jan 2024
Abstract excerpt
Stem cell therapy is an emerging treatment paradigm for stroke patients with remaining neurological deficits. While allogeneic cell transplants overcome the manufacturing constraints of autologous grafts, they can be rejected by the recipient's immune system, which identifies foreign cells through the human leukocyte antigen (HLA) system. The heterogeneity of HLA molecules in the human population would require a...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
